Tacrine Hydrochloride

盐酸他克林

Report date: 2023/04/25 14:52:28
NME

Base Information

Drug NameTacrine Hydrochloride
Drug Alias Nametacrinum塔克林四氢氨基吖啶tacrina特可林 +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcetylcholinesterase inhibitors
TargetsAcetylcholinesterase
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsAlzheimer Disease
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1993/09/09
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesShionogi & Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShionogi Inc
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN06DA01
Related LinksWikipediaDrugBankKEGG